16 December 2021 — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果